thymol has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, AR; Ahmadi, SS; Bahrami, A; Ferns, GA; Heravi-Faz, N; Qoorchi Moheb Seraj, F; Shahbeiki, F; Soltani, A; Talebpour, A | 1 |
| Chang, HT; Chen, IS; Chiang, AJ; Chou, CT; Hsu, SS; Huang, FD; Huang, JK; Jan, CR; Kuo, CC; Liang, WZ; Liao, WC; Lin, KL; Liu, SI; Tsai, JY | 1 |
2 other study(ies) available for thymol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Thymol has anticancer effects in U-87 human malignant glioblastoma cells.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cymenes; Glioblastoma; Humans; Parasympatholytics; Reactive Oxygen Species; RNA, Messenger; Temozolomide; Thymol; Tumor Suppressor Protein p53 | 2022 |
Effect of thymol on Ca2+ homeostasis and viability in human glioblastoma cells.
Topics: Apoptosis; Astrocytes; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fura-2; Glioblastoma; Homeostasis; Humans; Manganese; Thymol; Type C Phospholipases | 2011 |